Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-papillary muscle autologous bone marrow stem cell injection for ischemic mitral regurgitation
IRCT201308138860N5Phase 2Completed
- Sponsor
- Rajaie Cardiovascular Medical and Research Center
- Start
- Dec 2013
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous bone marrow stem cells in mitral regurgitation (MR), myocardial infarction (MI) and coronary arteriosclerosis, sponsored by Rajaie Cardiovascular Medical and Research Center. Started Dec 2013; status: completed.
02
Drugs
autologous bone marrow stem cells
03
Conditions
mitral regurgitation (MR)myocardial infarction (MI)coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT201308138860N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201308138860N5.